P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.295 MYR Market Closed
Market Cap: 1.9B MYR

Wall Street
Price Targets

PHARMA Price Targets Summary
Pharmaniaga Bhd

Wall Street analysts forecast PHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHARMA is 0.23 MYR with a low forecast of 0.152 MYR and a high forecast of 0.315 MYR.

Lowest
Price Target
0.152 MYR
49% Downside
Average
Price Target
0.23 MYR
22% Downside
Highest
Price Target
0.315 MYR
7% Upside
Pharmaniaga Bhd Competitors:
Price Targets
WRLD
World Acceptance Corp
14% Upside
CAH
Cardinal Health Inc
10% Upside

Revenue
Forecast

7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
7% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 14 years the compound annual growth rate for Pharmaniaga Bhd's revenue is 7%. The projected CAGR for the next 2 years is 2%.

Operating Income
Forecast

4% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
4% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 14 years the compound annual growth rate for Pharmaniaga Bhd's operating income is 4%. The projected CAGR for the next 3 years is 34%.

Net Income
Forecast

-1% / Year
Past Growth
106% / Year
Estimated Growth
Estimates Accuracy
-65%
Average Miss
-1% / Year
Past Growth
106% / Year
Estimated Growth
Estimates Accuracy
-65%
Average Miss

For the last 14 years the compound annual growth rate for Pharmaniaga Bhd's net income is -1%. The projected CAGR for the next 2 years is 106%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHARMA's stock price target?
Price Target
0.23 MYR

According to Wall Street analysts, the average 1-year price target for PHARMA is 0.23 MYR with a low forecast of 0.152 MYR and a high forecast of 0.315 MYR.

What is Pharmaniaga Bhd's Revenue forecast?
Projected CAGR
2%

For the last 14 years the compound annual growth rate for Pharmaniaga Bhd's revenue is 7%. The projected CAGR for the next 2 years is 2%.

What is Pharmaniaga Bhd's Operating Income forecast?
Projected CAGR
34%

For the last 14 years the compound annual growth rate for Pharmaniaga Bhd's operating income is 4%. The projected CAGR for the next 3 years is 34%.

What is Pharmaniaga Bhd's Net Income forecast?
Projected CAGR
106%

For the last 14 years the compound annual growth rate for Pharmaniaga Bhd's net income is -1%. The projected CAGR for the next 2 years is 106%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett